Skip to main content
NANOVEU LIMITED logo

NANOVEU LIMITED — Investor Relations & Filings

Ticker · NVU ISIN · AU0000024796 LEI · 5299003PDOQ5DPU98119 ASX Manufacturing
Filings indexed 626 across all filing types
Latest filing 2025-12-23 Capital/Financing Update
Country AU Australia
Listing ASX NVU

About NANOVEU LIMITED

https://nanoveu.com/

Nanoveu Limited specializes in the development of advanced materials and digital imaging solutions through nanotechnology. The company’s product portfolio includes EyeFly3D, a specialized film and software platform that enables glasses-free 3D visualization on mobile devices. Its Nanoshield product line features antimicrobial coatings and films that utilize copper ions to eliminate pathogens on frequently touched surfaces. Furthermore, the company is advancing EyeFyx technology, which aims to provide vision correction for individuals with presbyopia by manipulating digital screen output. Nanoveu focuses on integrating proprietary thin-film coatings with sophisticated algorithms to enhance display functionality and provide protective surface treatments across various consumer and commercial applications.

Recent filings

Filing Released Lang Actions
Exercise of Unlisted Options 2 pages 219.0KB
Capital/Financing Update Classification · 95% confidence The document is an ASX release dated 24 December 2025 from Nanoveu Limited announcing the issuance of ordinary shares following the exercise of unlisted options. It references compliance with the Corporations Act 2001 (Cth) and provides a notice under section 708A(5)(e) of the Act. The content is focused on a capital transaction (exercise of options leading to share issuance) and does not contain financial statements or detailed financial performance data. The document length is 4150 characters, which is relatively short and typical for a capital/financing update announcement. Therefore, the document fits best under the category of Capital/Financing Update (CAP).
2025-12-23 English
Application for quotation of securities - NVU 7 pages 21.2KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 2A - Application for quotation of securities' and details the application for quotation of securities on the ASX (Australian Securities Exchange). It includes information about securities issued due to options being exercised or convertible securities being converted, issue dates, number of securities, and their ranking. This is a formal announcement related to the quotation of new securities on the exchange, which corresponds to a share issue or capital change event. The document is not a financial report, earnings release, or management discussion, but rather a regulatory announcement about securities quotation. Therefore, the appropriate classification is 'Share Issue/Capital Change' (SHA). The document length (8148 characters) supports it being a full announcement rather than a brief notice or report publication announcement.
2025-12-23 English
Investor Webinar Presentation 24 pages 4.4MB
Investor Presentation Classification · 95% confidence The document is an ASX release dated 19 December 2025 from Nanoveu Limited. It announces an investor webinar presentation and includes presentation materials for investors. The content focuses on company updates, technology innovations, collaborations, and sales network establishment. It explicitly states it is an "Investor Webinar Presentation" and includes disclaimers typical for investor presentations. There is no detailed financial data, quarterly or annual results, or audit information. The document is lengthy (15,000 characters) and contains the presentation itself, not just an announcement of a report. Therefore, it fits the category of an Investor Presentation (IP).
2025-12-18 English
Nanoveu Reaches Final GDS Stage for 16nm ECS-DoT SoC 6 pages 911.5KB
Regulatory Filings Classification · 95% confidence The document is an ASX release dated 17 December 2025 from Nanoveu Limited announcing a major milestone in the development of its next-generation 16nm ECS-DoT SoC. The content focuses on technical details, product development progress, and strategic positioning of the new semiconductor technology. It is a corporate announcement about product development and technological advancement rather than a financial report, earnings release, or regulatory filing. There are no financial statements, earnings data, or management discussion of financial results. The document is not a report itself but an announcement of a milestone achievement. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Capital Update. It is a general corporate announcement about product development progress, which aligns best with Regulatory Filings (RNS) as a fallback category for miscellaneous announcements that do not fit other specific categories.
2025-12-16 English
Investor Webinar 2 pages 220.0KB
Regulatory Filings Classification · 95% confidence The document is an ASX release dated 17 December 2025 from Nanoveu Limited announcing an upcoming investor webinar. It outlines the topics to be discussed in the webinar, such as new technology developments, collaborations, and sales network establishment. There are no financial statements, detailed financial data, or comprehensive report content included. The document serves as an invitation and announcement for an event rather than a financial report or detailed investor presentation. It is also relatively short (4489 characters) and does not contain substantive financial analysis or results. Therefore, it fits best as a Regulatory Filing (RNS) since it is a general regulatory announcement and does not meet criteria for other specific categories like Investor Presentation or Earnings Release.
2025-12-16 English
EMASS and Semtech Collaborate on Low-Power Edge AI 4 pages 343.5KB
Capital/Financing Update Classification · 95% confidence The document is an ASX release dated 9 December 2025 from Nanoveu Limited announcing a strategic collaboration with Semtech on a technology integration involving low-power edge AI and LoRa transceivers. The content focuses on describing the collaboration, joint reference designs, demonstrations, and the potential market impact. There are no financial statements, no detailed financial performance data, no regulatory certifications, no voting results, no management or board changes, no merger or acquisition details, and no legal proceedings. The document is a corporate announcement about a business collaboration and product development, typical of a Capital/Financing Update or general corporate update. Given the nature of the announcement and the lack of financial data or regulatory filings, the best fitting category is Capital/Financing Update (CAP). The document length is over 10,000 characters and contains substantive information about the collaboration, not just a brief notice or report publication announcement. Therefore, the classification is CAP with high confidence.
2025-12-08 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.